Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital
Mendes D, Abrantes J, Rigueiro G, Pais AF, Penedones A, Alves C, Batel Marques F.
J Oncol Pharm Pract. 2020 Sep 16;1078155220957079. doi: 10.1177/1078155220957079.
2020